| Net Cash Provided by (Used in) Operating Activities |
$355,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$233,000,000 |
USD |
-278% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,000,000 |
USD |
99% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
25,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
25,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
100 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$120,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$652,000,000 |
USD |
55% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$51,000,000 |
USD |
42% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$298,000,000 |
USD |
15% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$51,000,000 |
USD |
-145% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$107,000,000 |
USD |
23% |
Q4 2024 |
FY 2024 |